If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWoodbois Regulatory News (WBI)

  • This share is currently suspended. It was suspended at a price of 0.03
  • There is currently no data for WBI

Align Research Obtala Ltd note update

24 May 2017 07:35

RNS Number : 0344G
Obtala Limited
24 May 2017
 

Obtala Limited

Acquisition of WoodBois adds a potential 13.4p upside to our current base case valuation of 30.52p

Obtala Limited is an Africa focussed forestry and agriculture company with a goal of becoming one of East Africa's largest sustainable food and timber producers.

 Acquisition of WoodBois International ApS

Obtala has announced that 75% owned forestry subsidiary Argento Limited is to acquire WoodBois International for a total consideration of $14.8 million (c.£11.4 million) in a mixture of cash and shares, subject to satisfactory due diligence. Completion is targeted for 30th June 2017.

 Sawn timber trader expanding into higher value verticals

WoodBois is engaged in the global trading of sawn timber which it sources from producers throughout Africa. The business also produces sawn timber planks from its concessions in the country of Gabon and is moving up the value chain by completing constructing of a veneer making facility.

 Obtala applies its financial strength towards WoodBois expansion

Obtala now has plans to rapidly expand the timber trading business, which to date has been constrained by a lack of access to capital. The immediate plan is to expand the sawmill from its current annual capacity of 24,000m³ sawn timber and upgrade the veneer facility to a planned annual capacity of 18,000m³ of veneer in 2017. Expansion of both business lines is estimated to cost c.$0.5 million in capex.

 Target price of 30.52p retained but WoodBois potential value is clear

With the WoodBois deal still subject to due diligence we retain our 30.52p DCF based fair value target price. However, having analysed the base financial case for the deal using a similar DCF approach to our core valuation, we believe that WoodBois could add further value to Obtala shareholders of around 13.4p per share. Conviction Buy stance reiterated.

To download the full note visit http://www.alignresearch.co.uk/cpt-company/obtala/

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAUOSWRBVAVUAR
Date   Source Headline
1st Apr 20191:12 pmRNSHolding(s) in Company
27th Mar 20197:00 amRNSEquity Raise and Group Restructuring Update
20th Mar 20191:20 pmRNSResults of General Meeting and Change of Name
14th Mar 20195:32 pmRNSHolding(s) in Company
13th Mar 20191:25 pmRNSHolding(s) in Company
11th Mar 20197:00 amRNSHolding(s) in Company
7th Mar 20197:00 amRNSEquity Raise
28th Feb 20197:00 amRNSNotice of General Meeting
21st Jan 20197:01 amRNSDirector/PDMR Shareholding
21st Jan 20197:00 amRNSLong Term Incentive Plan
16th Jan 20191:44 pmRNSHolding(s) in Company
14th Jan 20198:08 amRNSQuarterly Update - Replacement
14th Jan 20197:00 amRNSQuarterly Update
11th Jan 20197:00 amRNSAppointment of New Nominated Adviser and Broker
10th Jan 20197:00 amRNSGroup Reorganisation and Fundraising
21st Nov 201812:49 pmRNSUpdate re: Nominated Adviser
5th Nov 20187:00 amRNSHolding(s) in Company
2nd Nov 20183:19 pmRNSDirector/PDMR Shareholding
2nd Nov 20183:14 pmRNSTotal Voting Rights
2nd Nov 20187:00 amRNSDirector/PDMR Shareholding
1st Nov 201811:43 amRNSNominated Adviser Status
1st Nov 20187:00 amRNSDirector/PDMR Shareholding
31st Oct 20187:00 amRNSDirector/PDMR Shareholding
30th Oct 20184:02 pmRNSDirector/PDMR Shareholding
30th Oct 201810:01 amRNSFunding Closed
30th Oct 20188:01 amRNSCapital raise, board, name change,strategic update
22nd Oct 201810:19 amRNSHolding(s) in Company
2nd Oct 20187:00 amRNSQuarterly update
14th Sep 20181:12 pmRNSDirector/PDMR Shareholding
14th Sep 20189:30 amRNSDirector/PDMR Shareholding
13th Sep 201810:37 amRNSDirector/PDMR Shareholding
13th Sep 20189:32 amRNSDirector/PDMR Shareholding
12th Sep 20189:13 amRNSDirector/PDMR Shareholding
11th Sep 20182:57 pmRNSDirector/PDMR Shareholding
11th Sep 201811:01 amRNSDirector/PDMR Shareholding
10th Sep 20181:52 pmRNSDirector/PDMR Shareholding
5th Sep 201811:02 amRNSDirector/PDMR Shareholding
4th Sep 20183:41 pmRNSDirector/PDMR Shareholding
3rd Sep 20184:43 pmRNSHalf-year Report
29th Aug 20189:21 amRNSHolding(s) in Company
26th Jul 20184:10 pmRNSDirector/PDMR Shareholding
23rd Jul 201811:32 amRNSDirector/PDMR Shareholding
23rd Jul 201810:27 amRNSDirector/PDMR Shareholding
23rd Jul 201810:08 amRNSHolding(s) in Company
18th Jul 20185:05 pmRNSHolding(s) in Company
16th Jul 20189:19 amRNSDirector/PDMR Shareholding Amendment
13th Jul 20182:36 pmRNSHolding(s) in Company
13th Jul 20182:09 pmRNSDirector/PDMR Shareholding
11th Jul 201810:12 amRNSDirector/PDMR Shareholding
9th Jul 20182:18 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.